RecruitingType 1 Diabetes
Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The proposed study is designed to test the hypothesis that treatment of resveratrol for 12 weeks will improve both endothelin-B receptor (aim 1) and skeletal muscle mitochondrial function (aim 2) in people with type 1 diabetes.
Sponsor: Augusta University
You may qualify if…
- ✓ Men and premenopausal women
- ✓ All races
- ✓ Clinical diagnosis of insulin-dependent type 1 diabetes (patients only)
You may not qualify if…
- ✕ Clinical diagnosis of hepatic, cardiovascular, or renal disease
- ✕ Uncontrolled diabetes (HbA1C \>12%)
- ✕ Diabetic complications (i.e. neuropathy)
- ✕ Uncontrolled hypertension (\>140/90 mm Hg on therapy)
- ✕ Pregnancy
- ✕ Use of vasoactive medications
Where it's recruiting
Georgia
Augusta
Source: ClinicalTrials.gov · NCT04449198 · last updated 2025-01-28